News und Analysen
Presentation of the 2022 full-year results for the Julius Baer Group
Presentation of the 2022 full-year results for the Julius Baer Group
Impairment of Kairos goodwill following unprecedented difficult year for active asset managers
Impairment of Kairos goodwill following unprecedented difficult year for active asset managers
Interim Management Statement for the first ten months of 2022*
Interim Management Statement for the first ten months of 2022*
Julius Baer acquires stake in GROW Investment Group
Julius Baer acquires stake in GROW Investment Group
Presentation of the 2022 half-year results for the Julius Baer Group
Presentation of the 2022 half-year results for the Julius Baer Group
Julius Baer to cease charging clients negative interest rates
Julius Baer to cease charging clients negative interest rates
Julius Baer reaches settlement in disclosed legacy litigation case
Julius Baer reaches settlement in disclosed legacy litigation case
Julius Baer appoints Luigi Vignola to the Executive Board
Julius Baer appoints Luigi Vignola to the Executive Board
Julius Baer Group Ltd.: Execution of capital reduction
Julius Baer Group Ltd.: Execution of capital reduction
Julius Baer to expand into Qatar to drive the next phase of growth in the Middle East
Julius Baer to expand into Qatar to drive the next phase of growth in the Middle East
Julius Baer Group sells Fransad Gestion SA in a management buyout
Julius Baer Group sells Fransad Gestion SA in a management buyout
Julius Baer Group Ltd. places USD Perpetual Tier 1 Subordinated Bonds
Julius Baer Group Ltd. places USD Perpetual Tier 1 Subordinated Bonds
Julius Baer presents updated strategy, medium-term targets for 2023-2025 and sharpens capital distribution policy
Julius Baer presents updated strategy, medium-term targets for 2023-2025 and sharpens capital distribution policy
Interim Management Statement for the first four months of 2022*
Interim Management Statement for the first four months of 2022*
![Key Figures
31.7.2024](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
Key Figures 31.7.2024
Key Figures
31.7.2024
![Bellevue Group reports net profit of CHF 7.4 mn – stabilization of assets under management thanks to modest market rebound](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Bellevue Group reports net profit of CHF 7.4 mn – stabilization of assets under management thanks to modest market rebound
Bellevue Group reports net profit of CHF 7.4 mn – stabilization of assets under management thanks to modest market rebound
![Partners Group to acquire Eteck, a market-leading provider of sustainable decentralized heating and cooling solutions in the Netherlands](/assets/news/news17-d49b9ce9c87babddea210274f0f8d00a1cf706146ef6382020cc7ece83b76f6c.png)
Partners Group to acquire Eteck, a market-leading provider of sustainable decentralized heating and cooling solutions in the Netherlands
Partners Group to acquire Eteck, a market-leading provider of sustainable decentralized heating and cooling solutions in the Netherlands
![Cembra reports growth in net revenues of 6% and net income of 4% in the first half year](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
Cembra reports growth in net revenues of 6% and net income of 4% in the first half year
Cembra reports growth in net revenues of 6% and net income of 4% in the first half year
![HBM Healthcare Investments publishes Quarterly Report as at 30 June 2024 with key figures for the first three months of the 2024/2025 financial year](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
HBM Healthcare Investments publishes Quarterly Report as at 30 June 2024 with key figures for the first three months of the 2024/2025 financial year
HBM Healthcare Investments publishes Quarterly Report as at 30 June 2024 with key figures for the first three months of the 2024/2025 financial year
![Key Figures
15.7.2024](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Key Figures 15.7.2024
Key Figures
15.7.2024
![Partners Group reports solid AuM development in H1 and reconfirms full-year fundraising guidance](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Partners Group reports solid AuM development in H1 and reconfirms full-year fundraising guidance
Partners Group reports solid AuM development in H1 and reconfirms full-year fundraising guidance
![Partners Group’s announcement of AuM as of 30 June 2024](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Partners Group’s announcement of AuM as of 30 June 2024
Partners Group’s announcement of AuM as of 30 June 2024
![Key Figures
30.06.2024](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Key Figures 30.06.2024
Key Figures
30.06.2024
![Partners Group to acquire majority stake in FairJourney Biologics, a leading antibody discovery Contract Research Organization](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Partners Group to acquire majority stake in FairJourney Biologics, a leading antibody discovery Contract Research Organization
Partners Group to acquire majority stake in FairJourney Biologics, a leading antibody discovery Contract Research Organization
![Partners Group’s announcement of AuM as of 30 June 2024](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
Partners Group’s announcement of AuM as of 30 June 2024
Partners Group’s announcement of AuM as of 30 June 2024